• Home
  • About Us
    • Management
    • Thrust Areas
    • Disclaimer
    • Dr Boominathan’s Quotes
  • Ideas
    • Bio-Med Ideas
      • Ideas for Free
      • Bio-Pharma/Med Ideas
      • Audience Profile
      • Bio-Medical Ideas-7,900+
      • Bio-Med Res Grants Aid
      • p63 and p73 Community
      • How p63/p73/p53 Field Progresses
      • Noble Laureate’s work tracked by GBMD
      • Ideas were viewed by World’s Best 10 Universities
      • Submit your Ideas
    • miRNA Therapeutics
      • Intellectual Property Development
      • Licensing Opportunities
      • Partnerships
      • Investor opportunities
      • Educational Tools
      • Scientific Resources
  • Research
    • Research Focus
    • Research Themes
    • Research – II
    • Dr Boomi’s Contributions (Res)
    • Dr Boomi’s caliber (Sci)
    • Conference publications
    • Research Publications
    • Research Training
    • Ph.D/M.D/M.Tech Mentor
    • What Scientists Saying
    • Peer/Manuscript Review
    • Press/Media Release
    • Conferences/Meetings
  • B-MERIIT
    • Introduction
    • Founder
    • What We Assure
    • M.S program
      • M.S in Molecular Cancer Biology
      • M.S in Stem cell Biology & Regenerative Medicine
      • M.S in Mol. Medicine
      • M.S in Genome Biology
      • M.S in Bio-Medical Sciences
  • Model Building & Model Laboratory
    • Investor opportunities
    • Logo
    • Career guidance
    • Admission Details
  • Registration
    • Terms and conditions
  • Career/Opportunities
  • Contact Us

[GBMD] / [B-MERIIT]

Address:

No.101, 12th Cross,
Rainbow Nagar,
Puducherry-605 001, India.

Contact us:

0091-413-235-5879
Drboomi@genomediscovery.org

Research

  • Research Focus
  • Research Themes
  • Research – II
  • Dr Boomi’s Contributions (Res)
  • Dr Boomi’s caliber (Sci)

Recent Posts

  • Molecular mechanistic insights into how Prasugrel  attenuates pathogenesis-associated with Myocardial infarction and protects against myocardial dysfunction:   Prasugrel (Trade name:  Effient, Efient), a drug used to prevent blood clots, decreases IRF3, GM-CSF (Granulocyte-macrophage colony-stimulating factor) and GRK2(G protein-coupled receptor kinase) expression, inhibits undue leukocyte activation and invasion, suppresses recruitment of inflammatory cells, inhibits ventricular dilation, and promotes heart repair and survival, via up regulation of its target genes, 17/October/2019, 11.29 pm
© 2017 Genome Discovery. All Rights Reserved. Design by Staunch